Literature DB >> 11070011

Naturally occurring V1-env region variants mediate simian immunodeficiency virus SIVmac escape from high-titer neutralizing antibodies induced by a protective subunit vaccine.

H Petry1, K Pekrun, G Hunsmann, E Jurkiewicz, W Lüke.   

Abstract

Macaques which developed high-titer neutralizing antibodies (htNAb) after immunization with a virion-derived oligomeric envelope glycoprotein subunit vaccine were protected against a homologous simian immunodeficiency virus SIVmac challenge. Here we demonstrate that the htNAb could be overcome by V1-env region variants isolated ex vivo from an SIVmac-infected macaque. The results further suggest that the development of V1-env region neutralization escape mutants is also necessary for survival of the virus in infected macaques. The immunological capacity of a single variable region to induce neutralizing antibodies in vaccinated and infected macaques initiate new ideas for a successful vaccine strategy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070011      PMCID: PMC113200          DOI: 10.1128/jvi.74.23.11145-11152.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.

Authors:  K A Kent; E Rud; T Corcoran; C Powell; C Thiriart; C Collignon; E J Stott
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

2.  Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.

Authors:  D P Burns; R C Desrosiers
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.

Authors:  H Kestler; T Kodama; D Ringler; M Marthas; N Pedersen; A Lackner; D Regier; P Sehgal; M Daniel; N King
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  Sequence variation in the env gene of simian immunodeficiency virus recovered from immunized macaques is predominantly in the V1 region.

Authors:  N Almond; A Jenkins; A B Heath; P Kitchin
Journal:  J Gen Virol       Date:  1993-05       Impact factor: 3.891

5.  HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.

Authors:  C Bruck; C Thiriart; L Fabry; M Francotte; P Pala; O Van Opstal; J Culp; M Rosenberg; M De Wilde; P Heidt; J Heeney
Journal:  Vaccine       Date:  1994-09       Impact factor: 3.641

6.  Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus.

Authors:  S Benichou; R Legrand; N Nakagawa; T Faure; F Traincard; G Vogt; D Dormont; P Tiollais; M P Kieny; P Madaule
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

7.  Sensitive assay for neutralizing antibodies against AIDS-related viruses (HTLV-III/LAV).

Authors:  S Harada; D T Purtilo; Y Koyanagi; J Sonnabend; N Yamamoto
Journal:  J Immunol Methods       Date:  1986-09-27       Impact factor: 2.303

8.  The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.

Authors:  K Javaherian; A J Langlois; S Schmidt; M Kaufmann; N Cates; J P Langedijk; R H Meloen; R C Desrosiers; D P Burns; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

9.  Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.

Authors:  S Matsumi; S Matsushita; K Yoshimura; K Javaherian; K Takatsuki
Journal:  AIDS Res Hum Retroviruses       Date:  1995-04       Impact factor: 2.205

10.  Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.

Authors:  E A Emini; W A Schleif; J H Nunberg; A J Conley; Y Eda; S Tokiyoshi; S D Putney; S Matsushita; K E Cobb; C M Jett
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

View more
  10 in total

1.  Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain.

Authors:  Tahar Babas; Daniel Muñoz; Joseph L Mankowski; Patrick M Tarwater; Janice E Clements; M Christine Zink
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Envelope variable region 4 is the first target of neutralizing antibodies in early simian immunodeficiency virus mac251 infection of rhesus monkeys.

Authors:  Wendy W Yeh; Laura M Brassard; Caroline A Miller; Aravind Basavapathruni; Jinrong Zhang; Srinivas S Rao; Gary J Nabel; John R Mascola; Norman L Letvin; Michael S Seaman
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner.

Authors:  Cheryl J Saunders; Ruth A McCaffrey; Irina Zharkikh; Zane Kraft; Susan E Malenbaum; Brian Burke; Cecilia Cheng-Mayer; Leonidas Stamatatos
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys.

Authors:  Wendy W Yeh; Ishita Rahman; Peter Hraber; Rory T Coffey; Daiva Nevidomskyte; Ayush Giri; Mohammed Asmal; Svetlana Miljkovic; Marcus Daniels; James B Whitney; Brandon F Keele; Beatrice H Hahn; Bette T Korber; George M Shaw; Michael S Seaman; Norman L Letvin
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation.

Authors:  David H O'Connor; Adrian B McDermott; Kendall C Krebs; Elizabeth J Dodds; Jacqueline E Miller; Edna J Gonzalez; Timothy J Jacoby; Levi Yant; Helen Piontkivska; Ralph Pantophlet; Dennis R Burton; William M Rehrauer; Nancy Wilson; Austin L Hughes; David I Watkins
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Neuropathogenic SIVsmmFGb genetic diversity and selection-induced tissue-specific compartmentalization during chronic infection and temporal evolution of viral genes in lymphoid tissues and regions of the central nervous system.

Authors:  Aaron B Reeve; Nicholas C Pearce; Kalpana Patel; Katherine V Augustus; Francis J Novembre
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

Review 7.  Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Authors:  L Jean Patterson; Marjorie Robert-Guroff
Journal:  Expert Opin Biol Ther       Date:  2008-09       Impact factor: 4.388

8.  A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.

Authors:  Takeo Kuwata; Russell Byrum; Sonya Whitted; Robert Goeken; Alicia Buckler-White; Ronald Plishka; Ranjini Iyengar; Vanessa M Hirsch
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

9.  Reduced genetic diversity in lymphoid and central nervous system tissues and selection-induced tissue-specific compartmentalization of neuropathogenic SIVsmmFGb during acute infection.

Authors:  Aaron B Reeve; Kalpana Patel; Nicholas C Pearce; Katherine V Augustus; Heber G Domingues; Shawn P O'Neil; Francis J Novembre
Journal:  AIDS Res Hum Retroviruses       Date:  2009-06       Impact factor: 2.205

10.  SIVsm quasispecies adaptation to a new simian host.

Authors:  Linda J Demma; John M Logsdon; Thomas H Vanderford; Mark B Feinberg; Silvija I Staprans
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.